Original Research

FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer

Catalano M, Conca R, Petrioli R, Ramello M, Roviello G

Cancer Management and Research 2020, 12:10271-10278

Published Date: 19 October 2020